Turn Therapeutics Inc. (TTRX)
About Turn Therapeutics Inc.
Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$3.2M
- Total assets
- $12.2M
- Market cap
- $157.3M
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $5.9M
- Operating income
- -$5.9M
- Net income
- -$3.2M
- EPS (basic)
- $-0.12
- EPS (diluted)
- $-0.12
Balance sheet
- Total assets
- $12.2M
- Current assets
- $5.2M
- Total liabilities
- $7.5M
- Current liabilities
- $6.0M
- Shareholders’ equity
- $4.7M
Cash flow
- Operating cash flow
- -$2.6M
- Investing cash flow
- -$153.0K
- Financing cash flow
- $6.9M
- Net cash flow
- $4.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $157.3M
- EPS (diluted)
- $-0.12
- Shares outstanding
- 18.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 8, 2025
Turn Therapeutics Inc. (TTRX) Stock Price
- Reported a net loss of $3.2M.
- Trading 16% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Turn Therapeutics Inc..
Write a review
Turn Therapeutics Inc.: frequently asked questions
Is Turn Therapeutics Inc. an American company?
Turn Therapeutics Inc. is a US-based company headquartered in Westlake Village, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Turn Therapeutics Inc. headquartered?
Turn Therapeutics Inc. is headquartered in Westlake Village, California, United States.
Is Turn Therapeutics Inc. publicly traded?
Yes — Turn Therapeutics Inc. is a publicly traded company. Its stock trades under the ticker symbol TTRX on the NASDAQ.
What does Turn Therapeutics Inc. do?
Turn Therapeutics Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
